A Program That Has Quietly Reshaped American Industry
There is a particular kind of story in the defense innovation world that sounds too good to be true until you look at the numbers. A small company, sometimes just a handful of engineers working out of a garage or a university lab, applies for a government grant of $150,000 or $250,000. A few years later, that company employs thousands of people, generates billions in revenue, and provides technology that the United States military cannot operate without.
The Small Business Innovation Research program, better known as SBIR, has been producing these outcomes since 1982. Over those four decades, the program has invested more than $81 billion across 34,000 participating small businesses, making it the largest source of early-stage technology funding in the federal government and one of the most consequential economic development programs in American history. The program was reauthorized on April 14, 2026 through FY2031, with a new Strategic Breakthrough Award providing up to $30 million for technologies of exceptional national security importance, a signal that Congress sees the program not as a relic of Cold War R&D policy but as an increasingly vital instrument of great-power competition.
The challenge, of course, is that most SBIR-funded companies never achieve that kind of scale. The historical transition rate from Phase II research contracts to Phase III production contracts in the Air Force sits at roughly 8.8%. For every eleven companies that demonstrate a working prototype, fewer than one will secure the follow-on production funding that transforms a laboratory curiosity into a deployed capability. The rest enter the valley of death, that purgatory between successful demonstration and production contract where promising companies exhaust their capital, lose their best engineers to larger firms, and eventually pivot away from defense entirely.
But that 8.8% figure obscures enormous variation. Programs designed specifically to accelerate transition, such as the Air Force’s STRATFI initiative, have achieved transition rates of 63.5%. SOFWERX has demonstrated rates of 46%. The Defense Innovation Unit reports a 51% transition rate with $5.5 billion or more in combined contract ceilings. AFWERX alone saw 470 companies transition to Phase III in FY2024, generating $1.44 billion in production contracts from an ecosystem of more than 10,400 total contracts and $1.9 billion in committed funding. The valley of death is real, but it is not inevitable. The companies that cross it tend to share specific strategies, mindsets, and structural decisions that distinguish them from the companies that do not.
What follows are five case studies spanning four decades of the SBIR program. Each one illustrates a different pathway from small grant to scaled enterprise, and each carries lessons that are as relevant today as they were when the first SBIR check was written.
Case Study 1: Qualcomm and the CDMA Revolution
The story of Qualcomm is, in many ways, the founding myth of the SBIR program, the case study that program advocates cite most frequently because the numbers are almost absurdly disproportionate to the initial investment.
In 1985, Irwin Jacobs and six colleagues founded Qualcomm in San Diego with a focus on Code Division Multiple Access, or CDMA, a digital communication technology that the telecommunications industry broadly dismissed as impractical for commercial wireless networks. The company received $1.5 million in SBIR funding from the National Science Foundation to develop and demonstrate CDMA’s viability. That funding arrived at a critical moment. Qualcomm was a small company making an extraordinarily contrarian bet against the established GSM standard that Europe and much of Asia had already adopted, and the SBIR grant provided the runway to prove that CDMA could handle far more simultaneous users per cell site than existing technologies.
The technology worked. CDMA became the foundation of 3G wireless networks and, eventually, the evolutionary ancestor of the 4G LTE and 5G standards that underpin modern global telecommunications. Qualcomm grew to generate more than $11 billion in annual revenue, employs tens of thousands of people worldwide, and holds a patent portfolio that has shaped the architecture of every smartphone sold on the planet. The company’s licensing division alone generates billions in annual revenue from technologies whose foundational research was partially funded by a six-figure SBIR grant.
The lesson from Qualcomm is not simply that SBIR funding can catalyze enormous commercial outcomes, though it obviously can. The deeper lesson is about what the SBIR funding actually did for the company. It provided credibility. A small company making claims about a revolutionary wireless technology is easy to dismiss. A small company making the same claims while operating under a federal research contract has been vetted, at least at a basic level, by reviewers who understand the technical domain. That credibility accelerated Qualcomm’s ability to attract private investment, negotiate partnerships with carriers, and ultimately build the commercial relationships that turned a research project into a global standard.
Case Study 2: Symantec and the Birth of Commercial Cybersecurity
Before Symantec became synonymous with antivirus software and enterprise cybersecurity, it was a small research company with an idea about making computers secure against emerging digital threats. The company received a $245,000 SBIR grant for computer security research, funding that arrived during a period when cybersecurity was barely recognized as a distinct technical discipline, let alone a commercial market.
That early federal funding accomplished something that private capital alone could not have at the time: it validated cybersecurity as a legitimate area of technological investment. In the mid-1980s, venture capitalists were not lining up to fund companies working on computer viruses and network intrusion detection. The problems were real, as any ARPANET administrator could attest, but the commercial market for solutions was essentially nonexistent. The SBIR grant provided Symantec with both funding and, crucially, a customer, the federal government itself, that took the threat seriously and was willing to pay for solutions.
Symantec grew over the following decades into one of the defining companies of the cybersecurity industry. The company developed Norton Antivirus, which became the consumer-facing standard for PC security, and expanded into enterprise security, endpoint protection, and threat intelligence. By the time Broadcom acquired Symantec’s enterprise security division for $10.7 billion in 2019, the company had grown from a quarter-million-dollar SBIR recipient into one of the most valuable cybersecurity businesses in the world.
The Symantec story carries particular relevance for today’s founders because the cybersecurity landscape now bears structural similarities to the early Symantec era, just at a vastly larger scale. Emerging threat domains like AI-enabled attacks, quantum computing vulnerabilities, and supply chain compromise are creating new categories of risk that the market has not yet fully priced. Companies that secure early federal research contracts in these areas are positioning themselves the same way Symantec did: establishing technical credibility in a problem space before the commercial market fully materializes.
Case Study 3: iRobot PackBot and the Robotics Transition Blueprint
If Qualcomm represents the SBIR-to-commercial-giant pathway and Symantec represents the SBIR-to-market-creation pathway, then iRobot’s PackBot represents something different: the SBIR-to-production-contract pathway that the defense acquisition system is theoretically designed to support but rarely executes well.
iRobot received $4.4 million or more in SBIR funding from DARPA and the U.S. Army to develop small, portable robots for military applications. The company used that funding to develop PackBot, a rugged, remotely operated ground robot designed for explosive ordnance disposal, reconnaissance, and CBRN detection. What made iRobot’s approach distinctive was not just the technology itself, which was excellent, but the company’s deliberate focus on the operational needs of the end user from the earliest stages of development.
PackBot was not designed in a lab and then marketed to the military. It was designed with the military, incorporating feedback from soldiers and EOD technicians who would actually operate the system in combat conditions. That user-centered approach meant that when the time came to transition from prototype to production, PackBot had something that most SBIR technologies lack: a built-in constituency of operational advocates within the services who had used the system, trusted it, and were willing to fight for it in the budget process.
The results were remarkable. More than 4,000 PackBot units were deployed to Iraq and Afghanistan, and the Army awarded iRobot a $286 million indefinite-delivery/indefinite-quantity contract for continued PackBot production. The system saved an uncountable number of lives by allowing soldiers to investigate and neutralize improvised explosive devices without direct physical exposure.
The PackBot story offers a blueprint that remains highly relevant for today’s SBIR recipients. The company did not treat its SBIR contract as a research exercise. It treated it as the first phase of a production program, designing for manufacturability, building relationships with program offices, and cultivating operational champions who could advocate for transition funding when budget decisions were made. That intentionality, the decision to plan for Phase III from the first day of Phase I, is perhaps the single most important strategic choice an SBIR company can make.
Case Study 4: Shield AI and the Modern Defense Unicorn
Shield AI represents the new generation of SBIR success stories, companies that combine SBIR funding with venture capital, operational deployments, and aggressive commercial strategy to achieve scale at a pace that would have been unimaginable a decade ago.
The company received $4.17 million in SBIR funding through AFWERX for its autonomous drone technology. That SBIR funding was significant not because $4.17 million is a large sum in the context of defense procurement, but because it provided Shield AI with something that pure venture capital cannot buy: a formal contractual relationship with the Department of Defense that established the company as a legitimate defense supplier with relevant past performance.
Shield AI leveraged that foundation aggressively. The company developed Nova, an autonomous quadcopter system capable of navigating GPS-denied environments without a human pilot, and deployed it across four branches of the Department of Defense. The Nova system was designed from inception as a production platform, not a research demonstrator, with manufacturing, logistics, and maintenance considerations built into the architecture from the earliest prototype.
The growth trajectory has been extraordinary. Shield AI reached a valuation of $12.7 billion as the company continued to scale both its technology platform and its production capacity. From a $4.17 million SBIR contract to a valuation that exceeds many publicly traded defense primes, Shield AI’s trajectory compressed into roughly five years what traditionally took defense companies decades to achieve.
The Shield AI model carries a specific and actionable lesson: SBIR funding and venture capital are not competing strategies. They are complementary ones. The SBIR contract provides credibility, past performance, and direct access to military end users. Venture capital provides the growth funding necessary to scale manufacturing, hire cleared engineers, and build the compliance infrastructure that production contracts require. Companies that treat these as an either/or choice are making a strategic error. The most successful modern defense startups pursue both simultaneously.
Case Study 5: Castelion and the Hypersonic Breakthrough
Castelion may be the most striking recent example of what happens when a company combines SBIR funding with deep technical expertise, a willingness to tackle hard manufacturing problems, and perfect timing relative to national security priorities.
The company received $1.73 million in SBIR funding to develop advanced missile technology. What Castelion chose to work on, hypersonic weapons manufacturing, placed the company directly at the intersection of the Pentagon’s most urgent capability gap and its most frustrating industrial bottleneck. The United States has been struggling for years to field operational hypersonic weapons while China and Russia have deployed theirs. The problem has not been a lack of technical understanding of hypersonic flight physics. It has been the inability to manufacture hypersonic weapons at scale, affordably, and on a timeline relevant to the strategic competition.
Castelion attacked the manufacturing problem directly, developing production processes designed to build hypersonic missiles faster and at lower cost than the traditional defense primes had been able to achieve. The approach worked. The Navy awarded Castelion a production contract exceeding $105 million for hypersonic missile production, a validation of both the company’s technology and its manufacturing approach.
The progression from $1.73 million in SBIR funding to a $105 million Navy production contract represents one of the most dramatic return-on-investment stories in recent SBIR history. But the Castelion story is not primarily about the size of the numbers. It is about strategic alignment. Castelion chose to work on a problem that the Department of Defense has publicly identified as a top priority, where the existing industrial base has demonstrably failed to deliver adequate solutions, and where the barriers to entry, while high, are surmountable for a technically excellent team willing to invest in manufacturing innovation rather than just design innovation.
The Pattern Behind the Success
Across four decades and five very different companies, a consistent pattern emerges. The companies that successfully transitioned from SBIR grants to scaled defense enterprises share several characteristics that aspiring SBIR recipients should study carefully.
First, every one of these companies planned for production from day one. They did not treat SBIR as a research grant and then figure out commercialization later. Qualcomm used its NSF funding to demonstrate commercial viability, not just technical feasibility. iRobot designed PackBot for manufacturability during the prototype phase. Shield AI built its Nova system as a production platform from the first iteration. This orientation toward production shaped every technical decision, every partnership, and every hiring choice.
Second, they built relationships within the agencies that funded them. The federal contracting ecosystem rewards companies that understand the needs of their customers at a granular, operational level. iRobot’s PackBot succeeded because soldiers trusted it. Shield AI’s Nova succeeded because operators in GPS-denied environments needed it. The technology mattered, but the relationships and operational validation mattered just as much.
Third, they understood that SBIR funding is a beginning, not an end. The companies that fail to transition often treat their SBIR contracts as the primary revenue strategy rather than as a credential and springboard for larger programs. Qualcomm used SBIR to establish credibility and then raised private capital to build a global business. Shield AI combined SBIR with venture funding. Castelion used SBIR to prove a manufacturing approach and then pursued production contracts directly.
Fourth, the most successful SBIR companies address problems that the existing industrial base has failed to solve. The SBIR program exists, in large part, because the traditional defense primes cannot innovate fast enough in certain domains. Castelion succeeded because the primes had not delivered affordable hypersonic manufacturing. Shield AI succeeded because autonomous navigation in GPS-denied environments was a problem that legacy platforms could not solve. The SBIR program is designed to fill gaps, and the companies that identify genuine gaps, rather than incremental improvements on existing capabilities, tend to attract the strongest transition support.
The New SBIR Landscape
The SBIR ecosystem today looks substantially different from the one that funded Qualcomm in 1985 or even iRobot in the early 2000s. Several structural changes have made the program both more accessible and more competitive.
The SBIR program’s reauthorization through FY2031 introduced the Strategic Breakthrough Award, providing up to $30 million for technologies of exceptional importance. This represents a dramatic expansion of the funding ceiling beyond the traditional Phase I awards of $50,000 to $275,000 over six to twelve months and Phase II awards of $500,000 to $1.75 million over twenty-four months. Phase III contracts carry no funding ceiling and are executed using non-SBIR appropriations, which means the transition from SBIR to production contract can, in principle, scale to any size the acquiring agency is willing to fund.
AFWERX has emerged as the most aggressive transition accelerator in the SBIR ecosystem, with over $1.9 billion in committed funding and 10,400 contracts issued since 2019. The organization’s deliberate focus on transition, rather than just research funding, has produced measurably better outcomes than the traditional SBIR process.
Recent Phase III successes beyond the five case studies presented here further demonstrate the program’s scale. Anduril secured a Phase III SBIR contract worth $363 million through the Army. Darkhive, a micro-drone manufacturer, secured a $100 million IDIQ contract for autonomous systems. These are not outliers; they are indicators of a structural shift in how the Department of Defense uses the SBIR program as a genuine pipeline for production capability rather than a check-the-box small business set-aside.
What This Means for Your Company
If you are a small business or startup considering the SBIR program, the success stories above should be both inspiring and sobering. Inspiring because the program has demonstrably produced some of the most consequential technology companies of the past four decades. Sobering because the companies that succeeded did so through strategic intentionality, not luck.
The single most common mistake SBIR applicants make is treating the program as a source of R&D funding rather than as the first stage of a production business. The companies that succeed plan their Phase III strategy during Phase I. They identify their transition partner, usually a program office or operational unit within the relevant service branch, before they submit their Phase II proposal. They build compliance infrastructure (CMMC, ITAR, facility clearances) in parallel with technology development rather than sequentially after it. They cultivate relationships with operational end users who can advocate for transition funding.
The second most common mistake is isolation. SBIR companies that work alone tend to stay small. The companies that scale, from Qualcomm to Shield AI, build ecosystems around their technology: venture investors, strategic partners, prime contractor teaming arrangements, and congressional advocates who understand the capability gap the company is addressing.
The SBIR program is not a lottery. It is a system, and like all systems, it rewards people who understand how it works and position themselves accordingly.
The five companies profiled in this article did not succeed because they had better technology than their competitors. They succeeded because they understood the system, built the right relationships, and planned for production from the very first day. If you are building technology that the Department of Defense needs, the SBIR program remains one of the most powerful tools available to get that technology from your lab to the warfighter. The question is not whether the pathway exists. The question is whether you are prepared to walk it.
US Defense Group works with small businesses and startups at every stage of the defense contracting lifecycle, from first SBIR application through Phase III production scale-up. Through GovSeek, companies can identify SBIR topics, matching solicitations, and transition pathways aligned with their technology and capabilities. Through Launcher Station, emerging defense companies get the operational infrastructure, compliance support, and teaming connections needed to survive the valley of death and emerge as scaled defense suppliers.